Take loss on this trade. Earnings on Nov 12 but the bad news are already out.
The US FDA rejected its application for its arthritis drug and this had hit a snap on its pipeline.
Regardless of the company will recover or not, I'm trying to be a bit more disciplined in cutting losers.
Will see if my renewed commitment to cut loser will help to improving my overall portfolio performance or jeopardise it.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
- Trade Feed Decoder·11-04TOP当前评论仅支持在app查看。LikeReport
- Mortimer Arthur·11-05alvotech on the verge of breaking out... with 3 approvals near they might be able to hit $1 billion in revenue for 2026LikeReport
- Enid Bertha·11-05The market is giving up on this stock. Sad to see it happen, did not expect this to drop too 5 usd.LikeReport
